Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
Accidental exposure; FBE calling on behalf a nurse who reported GARDASIL 9 syringe had broken and injured another nurse in the practice while administering product on 22APR2025. Filing AE for the nurse injury and filing potential patient AE as it was not confirmed durin; FBE calling on behalf a nurse who reported GARDASIL 9 syringe had broken and injured another nurse in the practice while administering product on 22APR2025. Filing AE for the nurse injury and filing potential patient AE as it was not confirmed durin; This spontaneous report was received from a Nurse and refers to a(n) female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 22-Apr-2025, an unknown patient would be vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) 0.5 mL (strength, dose, dose number, frequency, vaccination scheme, route, anatomical location, lot # and expiration date were not reported), as prophylaxis (Case # 2282009); however, during the vaccination procedure, the Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) syringe had broken and injured a nurse in the practice while administering product (syringe broken, injury associated with device, accidental exposure to product). The outcome of the event was not reported.